The first multimodality coronary imaging catheter has recently received 510(k) clearance from the FDA. The LipiScan IVUS Coronary Imaging System (InfraReDx) device is the result of 10 years of ...

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced it has received CE Mark approval to begin commercialization of the ...

The addition of IVUS to a fixed-dose catheter thrombolysis regimen failed to facilitate thrombus resolution in patients with acute iliofemoral deep vein thrombosis in the BERNUTIFUL trial. The ...

September 2, 2010 — The US Food and Drug Administration has granted 510(k) clearance for a next-generation catheter-based coronary imaging system (LipiScan IVUS; InfraReDx Inc) to help clinicians ...

OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant potential to reduce procedural time and costs in treating coronary artery disease DualView imaging catheter ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Infraredx, Inc., a pioneer in intravascular imaging for mapping coronary artery disease, today announced the Makoto™ Intravascular Imaging System, and accompanying ...

Biomedical engineers have combined intravascular ultrasound with fluorescence lifetime imaging in a single catheter probe that can image the tiny arteries of a living heart. The new catheter can ...

Results from the Lipid-Rich Plaque (LRP) study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the ...

Volcano Corp out of San Diego, CA received regulatory approval on both sides of the Atlantic for its Visions PV .035 digital intravascular ultrasound imaging (IVUS) catheter. New features within the ...

Bolt Medical announced the intravascular ultrasound (IVUS) results of 22 patients enrolled in the RESTORE FIH (First in Human) Coronary feasibility clinical trial using the company's Bolt IVL™ ...